1. 要旨
2. 分類学と市場定義を含む業界紹介
3. 市場動向と成功要因（マクロ経済要因、市場ダイナミクス、最近の業界動向など
4. 世界市場の需要分析と予測（歴史的分析と将来予測を含む
5. 価格分析
6. 世界市場の分析と予測
6.1. 薬剤タイプ
6.2. 用途
6.3. エンドユーザー
7. 世界市場の分析と予測、薬剤タイプ別
7.1. イブリツモマブ
7.2. リツキシマブ
7.3. エプラツズマブ
7.4. トシツズマブ
7.5. リントズマブ
7.6. ラベツズマブ
7.7. トラスツズマブ
8. 世界市場の分析と予測、用途別
8.1. 非ホジキンリンパ腫（NHL）
8.2. 濾胞性リンパ腫
8.3. 乳がん
8.4. 卵巣がん
8.5. 骨肉腫
8.6. 黒色腫
8.7. 白血病
8.8. その他
9. 世界市場の分析と予測、エンドユーザー別
9.1. 病院
9.2. 外来手術センター
9.3. がん研究所
10. 世界市場の分析と予測、地域別
10.1. 北米
10.2. 中南アメリカ
10.3. 西ヨーロッパ
10.4. 東欧
10.5. 東アジア
10.6. 南アジア・太平洋
10.7. MEA
11. 北米主要セグメント別・国別売上高分析と予測
12. 中南アメリカ主要セグメント・国別売上高分析と予測
13. 西ヨーロッパの販売分析と予測、主要セグメント別および国別
14. 東ヨーロッパの販売分析と予測、主要セグメント別および国別
15. 東アジア主要セグメント別・国別売上高分析と予測
16. 南アジア・太平洋地域の売上高分析と予測、主要セグメント別および国別
17. MEAの売上高分析と予測、主要セグメント別および国別
18. 30ヵ国における医薬品タイプ別、用途別、エンドユーザー別の売上高予測
19. 市場構造分析、主要企業別シェア分析、競争ダッシュボードを含む競争展望
20.会社概要
20. Company Profile
20.1. GlaxoSmithKline plc
20.2. Bayer Healthcare Pharmaceuticals
20.3. BioSynthema, Inc.
20.4. Molecular Insight Pharmaceuticals
20.5. Telix Pharmaceuticals
20.6. Spectrum Pharmaceuticals, Inc.
20.7. MabVax Therapeutics Holdings, Inc.
20.8. Nordic Nanovector
20.9. Immunomedics, Inc.
20.10. Actinium Pharmaceuticals
20.11. NorthStar Medical Technologies
20.12. Clarity Pharmaceuticals
Radioimmunotherapy Market - Scope of ReportA recent study by Fact.MR on the radioimmunotherapy market offers a 10-year forecast for 2024 to 2034. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering radioimmunotherapy.
The study also provides the dynamics responsible for influencing the future status of the radioimmunotherapy market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the radioimmunotherapy market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.
Report Summary
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of radioimmunotherapy across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of radioimmunotherapy during the forecast period. Price point comparison by region with global average price is also considered in the study.
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of value (US$ Mn).
Estimates at global and regional levels for radioimmunotherapy are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global radioimmunotherapy market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the radioimmunotherapy market during the forecast period.
Country-specific valuation on demand for radioimmunotherapy has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Analysis on Competition
The report sheds light on leading manufacturers of radioimmunotherapy, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering radioimmunotherapy has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the radioimmunotherapy domain.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis and Forecast
6.1. Drug Type
6.2. Application
6.3. End User
7. Global Market Analysis and Forecast, By Drug Type
7.1. Ibritumomab
7.2. Rituximab
7.3. Epratuzumab
7.4. Tositumumab
7.5. Lintuzumab
7.6. Labetuzumab
7.7. Trastuzumab
8. Global Market Analysis and Forecast, By Application
8.1. Non Hodgkin Lymphoma (NHL)
8.2. Follicular Lymphoma
8.3. Breast Cancer
8.4. Ovarian Cancer
8.5. Osteosarcoma
8.6. Melanoma
8.7. Leukemia
8.8. Others
9. Global Market Analysis and Forecast, By End User
9.1. Hospitals
9.2. Ambulatory surgical centers
9.3. Cancer research institute
10. Global Market Analysis and Forecast, By Region
10.1. North America
10.2. Latin America
10.3. Western Europe
10.4. Eastern Europe
10.5. East Asia
10.6. South Asia & Pacific
10.7. MEA
11. North America Sales Analysis and Forecast, by Key Segments and Countries
12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
17. MEA Sales Analysis and Forecast, by Key Segments and Countries
18. Sales Forecast by Drug Type, Application, and End User for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
20.1. GlaxoSmithKline plc
20.2. Bayer Healthcare Pharmaceuticals
20.3. BioSynthema, Inc.
20.4. Molecular Insight Pharmaceuticals
20.5. Telix Pharmaceuticals
20.6. Spectrum Pharmaceuticals, Inc.
20.7. MabVax Therapeutics Holdings, Inc.
20.8. Nordic Nanovector
20.9. Immunomedics, Inc.
20.10. Actinium Pharmaceuticals
20.11. NorthStar Medical Technologies
20.12. Clarity Pharmaceuticals
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
